Overview
- 6 inspections across 6 sites are on record.
- 18 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-02-07.
At a glance
Inspections
6
Sites
6
Observations
18
Career since
Apr 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Morton Salt, Inc. | 7 Feb 2025 | Human Drugs | On file |
| FUJIFILM Diosynth Biotechnologies Denmark ApS | 12 Nov 2024 | Human Drugs | On file |
| Chemwerth Pharmaceutical Technology (Shanghai) Co. Ltd. | 3 Apr 2024 | Human Drugs | On file |
| Porton Pharma Solutions Ltd | 29 Mar 2024 | Human Drugs | |
| EUGIA Pharma Specialities Limited | 14 Dec 2017 | Human Drugs |
Sites inspected
Morton Salt, Inc.Grand Saline, United States1 insp.
FUJIFILM Diosynth Biotechnologies Denmark ApSHillerod, Denmark1 insp.
Chemwerth Pharmaceutical Technology (Shanghai) Co. Ltd.Shanghai, China1 insp.
Porton Pharma Solutions LtdChangshou, Chongqing, China1 insp.
EUGIA Pharma Specialities LimitedMedchal-Malkajgiri District, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Wayne D Mcgrath2 shared
Milva E Melendez Perales1 shared
Richard Ledwidge1 shared
Sony Mathews1 shared
Meisha R Waters1 shared
Meisha R Sampson1 shared
Full investigator report
Get the verbatim findings behind David D Anderson's 18 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site